Matches in SemOpenAlex for { <https://semopenalex.org/work/W64093766> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W64093766 endingPage "53" @default.
- W64093766 startingPage "B49" @default.
- W64093766 abstract "Most clinical trials of lipid intervention and coronary artery disease prevention have been conducted in study populations that exclude diabetic individuals. Three trials have conducted post hoc analyses of their diabetic subgroups. One of these was a primary intervention trial with gemfibrozil (Helsinki Heart Study). Although this trial found a reduction in coronary events, the numbers were too small to reach significance. The two other trials (the Scandinavian Simvastatin Survival Study [4S] and Cholesterol and Recurrent Events Trial [CARE]) were secondary intervention trials conducted with hydroxymethylglutaryl-CoA reductase inhibitors, simvastatin, and pravastatin. Both of these trials found a reduction in coronary events. Although these two trials present the strongest evidence in support of the clinical benefits of lipid reduction in diabetes, they must be interpreted with caution. They are post hoc subgroup analyses, they looked at mainly hypercholesterolemic populations, and they are secondary intervention studies. Four studies aimed at testing the lipid hypothesis specifically in diabetes are currently under way. Three of these studies (Fenofibrate Intervention and Event Lowering in Diabetes [FIELD], Collaborative Atorvastatin Diabetes Study [CARDS], and Lipids in Diabetes Study [LDS]) are primary prevention trials, with clinical events as the primary end point. FIELD uses micronized fenofibrate, CARDS uses atorvastatin, and LDS uses both micronized fenofibrate and cerivastatin alone or in combination. These trials are in the early stages of starting or recruiting. One study (Diabetes Atherosclerosis Intervention Study [DAIS]) using micronized fenofibrate is nearing completion. It is an angiographic study that combines those with and without preexisting clinical coronary disease." @default.
- W64093766 created "2016-06-24" @default.
- W64093766 creator A5053825317 @default.
- W64093766 date "2000-04-01" @default.
- W64093766 modified "2023-09-23" @default.
- W64093766 title "Lipid intervention trials in diabetes." @default.
- W64093766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10860191" @default.
- W64093766 hasPublicationYear "2000" @default.
- W64093766 type Work @default.
- W64093766 sameAs 64093766 @default.
- W64093766 citedByCount "27" @default.
- W64093766 countsByYear W640937662014 @default.
- W64093766 countsByYear W640937662015 @default.
- W64093766 countsByYear W640937662018 @default.
- W64093766 countsByYear W640937662021 @default.
- W64093766 crossrefType "journal-article" @default.
- W64093766 hasAuthorship W64093766A5053825317 @default.
- W64093766 hasConcept C126322002 @default.
- W64093766 hasConcept C134018914 @default.
- W64093766 hasConcept C1862650 @default.
- W64093766 hasConcept C2776329913 @default.
- W64093766 hasConcept C2777180221 @default.
- W64093766 hasConcept C2777482532 @default.
- W64093766 hasConcept C2778110834 @default.
- W64093766 hasConcept C2778163477 @default.
- W64093766 hasConcept C2778213512 @default.
- W64093766 hasConcept C2778670441 @default.
- W64093766 hasConcept C2778848681 @default.
- W64093766 hasConcept C2779519902 @default.
- W64093766 hasConcept C535046627 @default.
- W64093766 hasConcept C555293320 @default.
- W64093766 hasConcept C71924100 @default.
- W64093766 hasConceptScore W64093766C126322002 @default.
- W64093766 hasConceptScore W64093766C134018914 @default.
- W64093766 hasConceptScore W64093766C1862650 @default.
- W64093766 hasConceptScore W64093766C2776329913 @default.
- W64093766 hasConceptScore W64093766C2777180221 @default.
- W64093766 hasConceptScore W64093766C2777482532 @default.
- W64093766 hasConceptScore W64093766C2778110834 @default.
- W64093766 hasConceptScore W64093766C2778163477 @default.
- W64093766 hasConceptScore W64093766C2778213512 @default.
- W64093766 hasConceptScore W64093766C2778670441 @default.
- W64093766 hasConceptScore W64093766C2778848681 @default.
- W64093766 hasConceptScore W64093766C2779519902 @default.
- W64093766 hasConceptScore W64093766C535046627 @default.
- W64093766 hasConceptScore W64093766C555293320 @default.
- W64093766 hasConceptScore W64093766C71924100 @default.
- W64093766 hasLocation W640937661 @default.
- W64093766 hasOpenAccess W64093766 @default.
- W64093766 hasPrimaryLocation W640937661 @default.
- W64093766 hasRelatedWork W1986048333 @default.
- W64093766 hasRelatedWork W1991638827 @default.
- W64093766 hasRelatedWork W2038967042 @default.
- W64093766 hasRelatedWork W2039325578 @default.
- W64093766 hasRelatedWork W2127465745 @default.
- W64093766 hasRelatedWork W2373508336 @default.
- W64093766 hasRelatedWork W2407514981 @default.
- W64093766 hasRelatedWork W3107523676 @default.
- W64093766 hasRelatedWork W64093766 @default.
- W64093766 hasRelatedWork W91854456 @default.
- W64093766 hasVolume "23 Suppl 2" @default.
- W64093766 isParatext "false" @default.
- W64093766 isRetracted "false" @default.
- W64093766 magId "64093766" @default.
- W64093766 workType "article" @default.